ArticleBlood2016

Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.

Jitka Fucikova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.